…Jack Levin, to develop the Limulus amoebocyte lysate (LAL) test for the presence of gram-negative bacteria in injections during the 1960s. This test, which was cleared by the U.S. Food and Drug Administration in 1973 and first licensed in 1977, protects people from much of the harmful bacteria that could…
Read More